Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 11737
TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643165BDBM643165(US20240002372, Example 6)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643161BDBM643161(US20240002372, Example 3 | trifluoroacetate | US20...)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643168BDBM643168(US20240002372, Example 9)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643161BDBM643161(US20240002372, Example 3 | trifluoroacetate | US20...)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643163BDBM643163(US20240002372, Example 4 | trifluoroacetate)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643164BDBM643164(US20240002372, Example 5)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643159BDBM643159(US20240002372, Example 1)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643170BDBM643170(US20240002372, Example 11)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643166BDBM643166(US20240002372, Example 7)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643167BDBM643167(US20240002372, Example 8)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643169BDBM643169(US20240002372, Example 10)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 643171BDBM643171(US20240002372, Example 12)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
US Patent